vs
DMC Global Inc.（BOOM）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是DMC Global Inc.的1.4倍（$207.3M vs $143.5M），DMC Global Inc.净利率更高（-7.8% vs -62.0%，领先54.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -5.8%），DMC Global Inc.自由现金流更多（$9.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -7.3%）
DMC Global Inc.旗下DMC采矿服务是成立于1980年的采矿服务承包商，业务覆盖加拿大、美国、智利以及蒙古，为矿区开发与运营提供专业相关工程服务，是全球范围内颇具规模的专业采矿服务商。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BOOM vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.5M | $207.3M |
| 净利润 | $-11.2M | $-128.6M |
| 毛利率 | 17.1% | — |
| 营业利润率 | -7.8% | -54.7% |
| 净利率 | -7.8% | -62.0% |
| 营收同比 | -5.8% | 25.9% |
| 净利润同比 | -3871.6% | 3.5% |
| 每股收益（稀释后） | $-0.60 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $143.5M | $207.3M | ||
| Q3 25 | $151.5M | $159.9M | ||
| Q2 25 | $155.5M | $166.5M | ||
| Q1 25 | $159.3M | $139.3M | ||
| Q4 24 | $152.4M | $164.6M | ||
| Q3 24 | $152.4M | $139.5M | ||
| Q2 24 | $171.2M | $147.0M | ||
| Q1 24 | $166.9M | $108.8M |
| Q4 25 | $-11.2M | $-128.6M | ||
| Q3 25 | $-3.1M | $-180.4M | ||
| Q2 25 | $116.0K | $-115.0M | ||
| Q1 25 | $677.0K | $-151.1M | ||
| Q4 24 | $296.0K | $-133.2M | ||
| Q3 24 | $-101.3M | $-133.5M | ||
| Q2 24 | $4.0M | $-131.6M | ||
| Q1 24 | $2.6M | $-170.7M |
| Q4 25 | 17.1% | — | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 23.6% | — | ||
| Q1 25 | 25.9% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 25.4% | — |
| Q4 25 | -7.8% | -54.7% | ||
| Q3 25 | 0.4% | -106.9% | ||
| Q2 25 | 2.5% | -64.8% | ||
| Q1 25 | 4.1% | -102.6% | ||
| Q4 24 | -0.5% | -74.3% | ||
| Q3 24 | -97.7% | -94.6% | ||
| Q2 24 | 6.8% | -79.1% | ||
| Q1 24 | 4.0% | -151.9% |
| Q4 25 | -7.8% | -62.0% | ||
| Q3 25 | -2.0% | -112.8% | ||
| Q2 25 | 0.1% | -69.0% | ||
| Q1 25 | 0.4% | -108.5% | ||
| Q4 24 | 0.2% | -80.9% | ||
| Q3 24 | -66.5% | -95.7% | ||
| Q2 24 | 2.3% | -89.5% | ||
| Q1 24 | 1.5% | -156.8% |
| Q4 25 | $-0.60 | $-1.28 | ||
| Q3 25 | $-0.10 | $-1.81 | ||
| Q2 25 | $-0.24 | $-1.17 | ||
| Q1 25 | $0.04 | $-1.57 | ||
| Q4 24 | $-0.18 | $-1.34 | ||
| Q3 24 | $-8.27 | $-1.40 | ||
| Q2 24 | $0.24 | $-1.52 | ||
| Q1 24 | $0.01 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.9M | $421.0M |
| 总债务越低越好 | $50.6M | — |
| 股东权益账面价值 | $242.1M | $-80.0M |
| 总资产 | $635.8M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
| Q4 25 | $31.9M | $421.0M | ||
| Q3 25 | $26.4M | $202.5M | ||
| Q2 25 | $12.4M | $176.3M | ||
| Q1 25 | $14.7M | $127.1M | ||
| Q4 24 | $14.3M | $174.0M | ||
| Q3 24 | $14.5M | $150.6M | ||
| Q2 24 | $14.6M | $480.7M | ||
| Q1 24 | $20.4M | $112.3M |
| Q4 25 | $50.6M | — | ||
| Q3 25 | $56.5M | — | ||
| Q2 25 | $58.7M | — | ||
| Q1 25 | $72.4M | — | ||
| Q4 24 | $70.8M | — | ||
| Q3 24 | $74.2M | — | ||
| Q2 24 | $84.1M | — | ||
| Q1 24 | $88.0M | — |
| Q4 25 | $242.1M | $-80.0M | ||
| Q3 25 | $253.0M | $9.2M | ||
| Q2 25 | $253.9M | $151.3M | ||
| Q1 25 | $253.9M | $144.2M | ||
| Q4 24 | $251.0M | $255.0M | ||
| Q3 24 | $256.5M | $346.8M | ||
| Q2 24 | $416.0M | $432.4M | ||
| Q1 24 | $409.9M | $140.3M |
| Q4 25 | $635.8M | $1.5B | ||
| Q3 25 | $644.1M | $1.2B | ||
| Q2 25 | $645.0M | $1.3B | ||
| Q1 25 | $670.6M | $1.3B | ||
| Q4 24 | $671.3M | $1.5B | ||
| Q3 24 | $702.0M | $1.5B | ||
| Q2 24 | $869.5M | $1.6B | ||
| Q1 24 | $860.0M | $1.3B |
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $9.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.7% | -48.6% |
| 资本支出强度资本支出/营收 | 3.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $37.0M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $15.2M | $-99.8M | ||
| Q3 25 | $18.6M | $-91.4M | ||
| Q2 25 | $15.2M | $-108.3M | ||
| Q1 25 | $4.5M | $-166.5M | ||
| Q4 24 | $11.8M | $-79.3M | ||
| Q3 24 | $19.0M | $-67.0M | ||
| Q2 24 | $2.3M | $-77.0M | ||
| Q1 24 | $13.4M | $-190.7M |
| Q4 25 | $9.6M | $-100.8M | ||
| Q3 25 | $14.4M | $-92.7M | ||
| Q2 25 | $12.3M | $-110.7M | ||
| Q1 25 | $709.0K | $-167.8M | ||
| Q4 24 | $6.1M | $-79.5M | ||
| Q3 24 | $12.9M | $-68.6M | ||
| Q2 24 | $-204.0K | $-79.0M | ||
| Q1 24 | $10.5M | $-193.9M |
| Q4 25 | 6.7% | -48.6% | ||
| Q3 25 | 9.5% | -58.0% | ||
| Q2 25 | 7.9% | -66.5% | ||
| Q1 25 | 0.4% | -120.5% | ||
| Q4 24 | 4.0% | -48.3% | ||
| Q3 24 | 8.5% | -49.2% | ||
| Q2 24 | -0.1% | -53.7% | ||
| Q1 24 | 6.3% | -178.2% |
| Q4 25 | 3.9% | 0.5% | ||
| Q3 25 | 2.8% | 0.8% | ||
| Q2 25 | 1.9% | 1.5% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 3.7% | 0.1% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | 1.5% | 1.4% | ||
| Q1 24 | 1.8% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 131.43× | — | ||
| Q1 25 | 6.63× | — | ||
| Q4 24 | 39.90× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 5.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOOM
| Dyna Energetics Segment | $68.9M | 48% |
| Other | $57.0M | 40% |
| Nobel Clad Segment | $17.7M | 12% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
